Obstructive lung disease is usually a differential diagnostic consideration when a patient
presents with breathlessness or cough. Spirometry is the key diagnostic test used to confirm
airflow obstruction particularly in the primary care setting. Airflow obstruction that
completely resolves after administration of a bronchodilator, by definition, excludes a
diagnosis of COPD. Evaluation of obstructive lung disease must include pulmonary function
testing; bronchoreversibility testing is an adjunct in differentiating between asthma and
COPD. Bronchoreversibility cannot serve as an absolute diagnostic criterion for separating
asthma from COPD.
Vibration response imaging (VRI) technology provides a simple, radiation-free method to
image the lungs, by visualizing vibration energy (lung sounds) emitted during respiration
cycle. In this study, regional quantitative and qualitative information on vibration
response is compared with spirometry in assessing lungs function of COPD and Asthma
- Able and willing to read, understand, and provide written Informed Consent
- Male or Female in the age range of 18-85 years
- Patients referred for evaluation of known or suspected obstructive airways disease.
- Subject is referred for pulmonary function testing with pre-and post- bronchodilator
- BMI > 21
- Patients who are treated with Bronchodilators should go through a washout period
prior the VRI procedure according to the Pulmonary Function Laboratory protocol.
- Stable clinical condition at study baseline evaluation.
- Chest wall deformation
- Spine deformation (including severe scoliosis)
- Potentially contagious skin lesion on the back
- Skin lesion that would interfere with sensor placement
- Pregnant or lactating females.